Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

STAA - STAAR SURGICAL CO

IEX Last Trade
24.465
-0.045   -0.184%

Share volume: 9,851
Last Updated: Thu 26 Dec 2024 08:30:05 PM CET

PREVIOUS CLOSE
CHG
CHG%
$24.51
-0.05
-0.18%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.31%
1 Month
-11.01%
3 Months
-26.28%
6 Months
-45.13%
1 Year
-21.60%
2 Year
-48.40%
Key data
Stock price
$24.46
P/E Ratio 
97.97
DAY RANGE
$24.24 - $24.76
EPS 
$0.34
52 WEEK RANGE
$24.82 - $52.68
52 WEEK CHANGE
-$22.21
MARKET CAP 
1.628 B
YIELD 
N/A
SHARES OUTSTANDING 
49.188 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
1.61
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$695,280
AVERAGE 30 VOLUME 
$595,519
Company detail
CEO: Caren L. Mason
Region: US
Website: staar.com
Employees: 960
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

STAAR Surgical Company designs, develops, manufactures, markets, and sells implantable lenses for the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems.

Recent news